Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co LtdfiledCriticalYamanouchi Pharmaceutical Co Ltd
Priority to JP2262781ApriorityCriticalpatent/JPS57136561A/ja
Publication of JPS57136561ApublicationCriticalpatent/JPS57136561A/ja
Publication of JPH0212948B2publicationCriticalpatent/JPH0212948B2/ja
Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: Synthesis and pharmacological properties of 2-phenyl-4'-[(2, 3, 4, 5-tetrahydro-1H-1-benzazepin-1-yl) carbonyl] benzanilide derivatives
Nouveaux dérivés aminoalkyl naphtaléniques, leurs sels d'addition d'acide et le procédé de préparation ainsi que l'application en thérapeutique de ces dérivés et sels